Like
Comment
Share
Drag to reposition cover
Like
Comment
Share
Like
Comment
Share
https://www.selleckchem.com/pr....oducts/telratolimod.
Background Chronic use of proton-pump inhibitors (PPIs) is common in kidney transplant recipients (KTRs). However, concerns are emerging about the potential long-term complications of PPI therapy. We aimed to investigate whether PPI use is associated with excess mortality risk in KTRs. Methods and findings We investigated the association of PPI use with mortality risk using multivariable Cox proportional hazard regression analyses in a single-center prospective cohort of 703 stable outpatient KTRs, who visited the outpatient clinic
Like
Comment
Share
Load more posts
About
Makeover your area with the opulent interior remodelling services offered by Hagcuae.com. We realise your concept, whether it's for an expansive workplace layout or an imaginative house design. Find out the difference now.
Likes
(14)
Crop your avatar